StonvexLoading…
StonvexStonvexStonvexCore line items from LPTH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q1 2025 2025-03-31 | Q4 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $50.56M | $31.41M | $24.99M | $15.83M |
Operating Income | $-15.36M | $-11.10M | $-7.31M | $-3.86M |
Net Income | $-16.40M | $-9.41M | $-7.82M | $-2.61M |
EPS (Diluted) | $-0.33 | $-0.27 | $-0.19 | $-0.11 |
Total Assets | $144.27M | $148.56M | $81.42M | $45.83M |
Total Liabilities | $31.38M | $36.39M | $31.30M | $19.13M |
Cash & Equivalents | $55.24M | $73.57M | $6.48M | $3.20M |
Free Cash Flow OCF − CapEx | $-6.96M | $736.01K | $-6.26M | $-2.60M |
Shares Outstanding | 61.21M | 54.44M | 42.89M | 39.89M |